Global Infectious Diseases Partnering Deal Trends, Players and Financials Directory 2019

NEXT STORY
Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
PREV STORY
Precision Therapeutics Gains Extension for Nasdaq Compliance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saniona AB: Saniona publishes its interim report for the first quarter 2017

PRESS RELEASE 11 May 2017 Financial highlights Q1 2017 (Q1 2016) ·         Net revenues were ...

author_avatar
NASDAQ Market News

World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board

TEL AVIV, Israel, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), ...

author_avatar
NASDAQ Market News

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit ...

author_avatar
NASDAQ Market News